Chemists' body seeks action against startups for unauthorised tampering, repacking of medicine strips
In a letter dated July 30, the BDCDA claimed that such actions are in contravention of the Drugs and Cosmetics Act, 1940, and Rules, 1945. 'Such tampering and repacking of medicine strips threaten patient safety, undermine ethical pharmacy practices, and erode confidence in the regulatory framework,' the letter stated.
Pointing out that the All India Organisation of Chemists and Druggists (AIOCD) has already taken up the issue of one such startup at the national level, the BDCDA has said that tampering with statutory packaging, unlawfully repacking medicines, and disregarding essential stability and labelling norms by the two health-tech companies put public health at risk.
Specific violations
Highlighting specific violations under the Drugs and Cosmetics Act, 1940, and Rules, 1945, BDCDA president B. Thirunavukkarasu told The Hindu that such actions amounted to willful destruction or removal of statutory labels, batch numbers, expiry dates, MRP, and mandatory warnings - effectively stripping medicines of their legally required safeguards, and thereby endangering consumer safety under Rule 96 and Rule 97 of the Act.
Compromising the stability, potency, and therapeutic efficacy of medicines by exposing them to contamination and temperature variations through improper handling, storage, and repackaging practices amounted to violation of Schedule P1, he said.
GMP and GSP violations
'Carrying out repacking in unlicensed, non-compliant, and uncontrolled environments grossly violates the principles of Good Manufacturing Practices (GMP) and Good Storage Practices (GSP) mandated under the law. Besides, misrepresenting these unlawful and unethical acts as 'tech-enabled innovations', or 'patient-friendly services' mislead consumers and erode the credibility of India's ethical pharmacy community,' he said.
Apart from all these violations, the sale of medicines through online platforms continues unchecked, lacking any legal authorisation or structured regulatory mechanism, Mr. Thirunavukkarasu added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Karnataka government set to regulate private ambulances by amending law
Bengaluru: The state govt has decided to amend the law to regulate private ambulances, especially their fares. "We'll be coming out with an amendment to the Karnataka Private Medical Establishments (KPME) Act any day and bring all ambulance service providers under its ambit. Tired of too many ads? go ad free now This will allow us to regulate ambulance-hiring charges, grade fixation, service, etc," health and family welfare minister Dinesh Gundu Rao said. "At present, there's no licensing or specific registration facilities for ambulances and mobile medical units. Both of these will be brought under the KPME Act," he added. Rao's statement came after reports about a private ambulance charging Rs 8,500 to take a patient from Goraguntepalya to Victoria Hospital. "The health department has already taken the issue of private ambulances charging exorbitant rates seriously... I appeal that the health sector should be viewed with a service mindset and not just from a business perspective," the minister had posted on social media. Health officials told TOI the state govt aims to follow the Singapore model that has a central command centre, which will be used to track and monitor both private and govt ambulances. This could be a game-changer in emergency response as ambulances will be strategically stationed across the city and state, and not just at hospitals, an official added. At present, govt ambulances are equipped with a GPS tracker to help patients get to the nearest healthcare facility. The govt's 108 service has 88 ambulances across the city, but private ambulances run in the hundreds in Bengaluru alone. The new system would prevent underhand dealings among ambulance drivers to take patients to certain hospitals, a private hospital doctor opined.
Indian Express
3 hours ago
- Indian Express
Gujarat to prepare SOPs to stop duplicate, fake medicines from entering state
The Gujarat government, in a statement on Tuesday, said it is in the process of formulating Standard Operating Procedures (SOPs) to enhance detection and seizures of duplicate and fake medicines from entering the state. 'Recently, it came to the notice of the state government that fake medicines are entering (Gujarat). They are being sourced from outside the state and sold in some places inside the state. Gujarat's Food and Drug Control Administration (FDCA) has also taken action by conducting on-site inspections. To make this more stringent and strict, the government will prepare an SOP for the inspection of medicines coming from outside the state into Gujarat,' Health Minister Rushikesh Patel was quoted as saying. The SOPs would make registration of imported medicines mandatory, require registration of transporters carrying medicines and cancellation of licenses of chemists or wholesalers who are caught in such dealing with fake medicines. The SOPs will also require people to strictly follow the Drugs and Cosmetics Act. Besides, expensive and 'fast-moving' medicines will be closely monitored. The state government will also start three new testing labs in addition to the existing NABL-certified laboratory in Vadodara. To intensify on-site testing, 10 sets of state-of-the-art hand-held devices (Raman Spectrometer with Advanced Technology) will be purchased. Further, a flying squad will be formed. Patel added that with the implementation of these SOPs, Gujarat will become the first state in the country to adopt 'zero-tolerance' towards duplicate and fake medicines. 'The government will take intensive action to prevent fake/spurious/counterfeit medicines from outside the state in Gujarat. In the last 4 years, raids were conducted to prevent counterfeit medicines/cosmetics in the state and more than Rs 6 crore (worth of) medicines/cosmetics were seized…about 75 persons/firms were found involved and action was taken against them,' a statement read. Speaking about the type of activities unearthed so far, the statement said, 'In most of these cases, persons who do not have a valid license for buying, selling and storing medicines are involved and investigation has also revealed that in most of the cases, counterfeit medicines come from outside the state.'
Business Standard
4 hours ago
- Business Standard
Druman Pharma Introduces Infanite8: Ushering a New Era in Everyday Wellness
Mumbai, India – In a remarkable stride towards shaping the future of holistic health, Druman Pharma proudly announces the official launch of Infanite8, a new-age nutraceutical brand designed to bring wellness within everyone's reach. Rooted in innovation, accessibility, and care, Infanite8 is poised to become one of Asia's most promising and fastest-growing wellness brands. Infanite8 emerges at a time when the demand for preventive healthcare and nutritional supplements is at an all-time high. With growing awareness around immunity, mental wellness, and lifestyle-related disorders, the need for effective and reliable wellness solutions has never been more urgent. Positioned at the intersection of nature and science, Infanite8 offers a curated range of nutraceutical products designed to support everyday health in a smarter, more meaningful way. The product portfolio includes a wide selection of science-backed supplements: multivitamins for overall health, Omega-3 fatty acids for heart and brain function, immune support formulations to strengthen daily defense, curcumin-based anti-inflammatory tablets to help combat internal inflammation, and lung detox supplements developed specifically for today's urban living conditions. Each product is thoughtfully formulated using premium-quality ingredients that undergo stringent quality checks and multiple levels of testing. By blending traditional wisdom with modern scientific research, Infanite8 ensures efficacy, safety, and ease of use. 'Infanite8 was born out of the idea that wellness should not be complicated; it should be simple, effective, and empowering,' said a spokesperson at Druman Pharma. 'Our vision is to build a healthier world where individuals feel confident in taking control of their wellbeing, and where daily self-care becomes second nature,' added Rahi Ravi Jain, reflecting the brand's long-term mission. Infanite8's launch is a significant chapter in Druman Pharma's journey a company already known for its commitment to ethical healthcare, scientific integrity, and social responsibility. The new brand brings together years of pharmaceutical expertise, deep research capabilities, and a clear intent to bridge the gap between preventive health and everyday convenience. With India witnessing a shift towards proactive health choices, Infanite8 is here to answer that call offering solutions that go beyond temporary relief or one-size-fits-all approaches. The brand is dedicated to making wellness not just a personal goal, but a lifestyle habit that is rooted in trust, transparency, and sustained care. In a country where rising stress levels, poor diets, and sedentary lifestyles have become common, Infanite8 steps in as a trusted ally for long-term wellbeing. Every formulation under the Infanite8 label is manufactured with world-class standards, following Good Manufacturing Practices (GMP) and other stringent regulatory compliances. This ensures that consumers get nothing but the best supplements that are pure, potent, and proven. What truly sets the brand apart is its honest approach to wellness: no exaggerated claims, no shortcuts, just thoughtfully developed products that deliver on their promise. Infanite8 aims to serve a wide demographic—from busy professionals and young adults to homemakers and the elderly—understanding that health is not one-size-fits-all. Whether it's about improving energy levels, boosting mental clarity, supporting respiratory health, or reinforcing immunity, there is an Infanite8 product designed to meet those needs. Additionally, Infanite8's commitment to wellness extends beyond product delivery. The brand will soon introduce personalized wellness content, expert guidance, and lifestyle support through its digital platforms to help individuals make more informed decisions. This holistic approach ensures that users are not just buying a supplement, but becoming part of a movement toward healthier living. The launch of Infanite8 also marks Druman Pharma's deeper foray into direct-to-consumer health offerings, making advanced wellness solutions more accessible across both urban and semi-urban markets in India. With a robust online presence and a rapidly expanding distribution network, Infanite8 aims to become a household name in the nutraceutical segment. It plans to build strong community engagement and consumer education to create real impact across diverse population segments. In a world where wellness often comes with overwhelming choices and marketing noise, Infanite8 simplifies the journey, offering clear, science-supported guidance and products that fit seamlessly into daily routines. For today's conscious consumer, this combination of transparency, quality, and accessibility is not just desirable, it's essential. For those looking to invest in long-term health and wellbeing, Infanite8 isn't just another supplement brand; it's a movement towards mindful living, informed choices, and a future where wellness is no longer a luxury but a way of life. To explore the full product range and learn more, visit:
